$CRCW

The Crypto Company (OTCMKTS:CRCW) Sees Large Decline in Short Interest

The Crypto Company (OTCMKTS:CRCW) reported a sharp drop in short interest in May, with 77,793 shares short as of May 15, down 85.2% from 523,885 shares on April 30, according to the article. Using an average volume of 28,519,394 shares, the days-to-cover ratio is listed as 0.0.

Original reporting
Published May 28, 2026, 2:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 28, 2026, 3:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
The Crypto Company (OTCMKTS:CRCW) Sees Large Decline in Short Interest — source image
Decision brief

The 30-second read

$CRCWNeutralLow
01

Why it matters

The key event is the reported 85.2% reduction in short interest by May 15, which could reduce downside pressure if shorts were covering; however, the stock’s $0.00 quote and very low days-to-cover suggest the signal may be distorted by microstructure/illiquidity.

02

Market read

Traders may monitor for any squeeze-like behavior, but the article’s liquidity/price presentation makes the practical trading edge uncertain.

03

What to watch

The article provides no details on borrow availability, lender constraints, or whether the stock is effectively suspended/illiquid; those factors can dominate any short-covering narrative.

Relevance 6/10Novelty 6/10Timing: after May short-interest update (as of May 15)

Background

CRCW is described as a crypto-related company with no significant operations and prior distributed-ledger consulting/education and blockchain infrastructure work.

Company-level read

Ticker impact

$CRCWNeutralLow confidence
Context

Article reports a sharp May decline in CRCW short interest (down 85.2% vs April 30) and near-zero days-to-cover.

Expected impact

Low/uncertain near-term impact; any move is more likely driven by microstructure/illiquidity than fundamentals.

Evidence & confidence

The only new datapoint is short-interest reduction; the article also shows $0.00 pricing and very low days-to-cover, which can reflect data/quote artifacts rather than a tradable squeeze setup.

Market effects

Limited read-across to crypto/ledger sector because the issuer is described as having no significant operations.

None indicated.

None indicated.

Counterpoint

Short-interest drops can reflect reduced reporting interest, delisting/liquidity changes, or position closures unrelated to bullish fundamentals—especially with $0.00 pricing.

Key entities

  • CRCW

    Subject of the article; short interest fell to 77,793 shares as of May 15.

Related articles

$SMCIMed

Super Micro Computer Landed $60 Billion in Orders Last Quarter, but Trades at Just $30

Super Micro Computer (SMCI) said it booked over $60B in new orders in its fiscal Q4 ended June 30, lifting backlog to a record. It guided FY2026 revenue near the low end of $11B to $12.5B and gross margins at 15% to 17%. The company also plans $7B equity financing for AI server orders, noting some orders may not be firm and citing an independent review tied to export control issues.

$CSCOMed

Cisco Stock Is Finally Pricing In A New Growth Story

Cisco raised full-year revenue and EPS guidance on May 13, 2026, citing AI infrastructure demand. Management expects about $9 billion in FY2026 AI orders from hyperscalers and cited 5 hyperscaler design wins in Q3. Cisco shares rose about 20% since, with product orders up 19% YoY excluding hyperscaler growth. Options imply 41% IV ahead of the next catalyst.

$RMDMed

Off Into Weekend, As Early Work Undone

ResMed (ASX:RMD) fell 8.29% on Friday and is 3.09% lower for the week after a strong run. The company reported a solid Q4, with FY26 revenue up 10% to $5.7b, gross Q4 margin 62.3%, FY EPS up 17% to $11.17, and a 10% dividend increase to $0.66. Morgan Stanley downgraded to Equal Weight and cut its price target, citing cooling growth and Philips’ potential US return in 2027.